SplitNov 9, 2026, 08:06 AM
Onconetix Completes 1-for-10 Reverse Stock Split
AI Summary
Onconetix, Inc. has officially completed its previously announced 1-for-10 reverse stock split. The split, effective November 6, 2026, reduced the number of outstanding common shares from approximately 6.7 million to about 670,000. Fractional shares were settled in cash, and adjustments were made to outstanding equity awards, convertible securities, and warrants. The company's stock began trading on a split-adjusted basis on The Nasdaq Capital Market under its existing ticker symbol 'ONCO'.
Key Highlights
- Onconetix, Inc. completed a 1-for-10 reverse stock split effective November 6, 2026.
- The reverse stock split reduced outstanding shares from approximately 6.7 million to 670,000.
- No fractional shares were issued; stockholders received cash for fractional entitlements.
- Adjustments were made to equity awards, convertible preferred stock, and warrants.
- The common stock began trading on a split-adjusted basis on Nasdaq under ticker ONCO.
Price Impact
More from ONCO